Literature DB >> 8720509

Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study.

R Arai1, N Karasawa, I Nagatsu.   

Abstract

The aim of the present study is to examine whether serotonergic fibers of the striatum of the rat contain aromatic L-amino acid decarboxylase (AADC). By use of a double-labeling immunofluorescence method, we showed that AADC was localized in serotonergic fibers of the striatum and cerebral cortex as well as in serotonergic cell bodies of the midbrain raphe nuclei. We previously demonstrated that serotonergic fibers of the rat striatum contained dopamine after intraperitoneal injection of L-dopa. These findings suggest that dopamine is produced from the injected L-dopa in serotonergic fibers of the rat striatum.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8720509     DOI: 10.1016/0006-8993(95)01281-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  The roles of striatal serotonin and L -amino-acid decarboxylase on L-DOPA-induced Dyskinesia in a Hemiparkinsonian rat model.

Authors:  Sukju Gil; Changhwan Park; Jeongeun Lee; Hyunchul Koh
Journal:  Cell Mol Neurobiol       Date:  2010-03-16       Impact factor: 5.046

Review 2.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 3.  Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data.

Authors:  B Scholtissen; F R J Verhey; H W M Steinbusch; A F G Leentjens
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 4.  Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Mol Neurobiol       Date:  2012-01-06       Impact factor: 5.590

5.  Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.

Authors:  Tomas Björklund; Thomas Carlsson; Erik Ahlm Cederfjäll; Manolo Carta; Deniz Kirik
Journal:  Brain       Date:  2010-02-02       Impact factor: 13.501

Review 6.  The serotonergic system in motor and non-motor manifestations of Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox
Journal:  Exp Brain Res       Date:  2013-06-28       Impact factor: 1.972

7.  Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats.

Authors:  Anupom Borah; Kochupurackal P Mohanakumar
Journal:  Cell Mol Neurobiol       Date:  2007-10-13       Impact factor: 5.046

8.  Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency.

Authors:  Maria Stamelou; Niccolo E Mencacci; Carla Cordivari; Amit Batla; Nick W Wood; Henry Houlden; John Hardy; Kailash P Bhatia
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

9.  Dyskinesia is Closely Associated with Synchronization of Theta Oscillatory Activity Between the Substantia Nigra Pars Reticulata and Motor Cortex in the Off L-dopa State in Rats.

Authors:  Jiazhi Chen; Qiang Wang; Nanxiang Li; Shujie Huang; Min Li; Junbin Cai; Yuzheng Wang; Huantao Wen; Siyuan Lv; Ning Wang; Jinyan Wang; Fei Luo; Wangming Zhang
Journal:  Neurosci Bull       Date:  2020-11-19       Impact factor: 5.203

10.  Striatal glutamate release in L-DOPA-induced dyskinetic animals.

Authors:  Nina Nevalainen; Martin Lundblad; Greg A Gerhardt; Ingrid Strömberg
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.